tiprankstipranks
Trending News
More News >
NextCell Pharma AB (SE:NXTCL)
:NXTCL
Sweden Market

NextCell Pharma AB (NXTCL) Cash flow

Compare
1 Followers

NextCell Pharma AB Cash Flow

SE:NXTCL's free cash flow for Q4 2025 was kr-12.50M. For the 2025 fiscal year, SE:NXTCL's free cash flow was decreased by kr― and operating cash flow was kr-10.77M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 25Dec 24Dec 23Dec 22
Operating Cash Flow
kr -38.86Mkr ―kr -37.78Mkr -43.83Mkr -33.31M
Investing Cash Flow
kr -4.24Mkr ―kr -83.51Kkr -4.10Mkr -9.37M
Financing Cash Flow
kr 35.03Mkr ―kr 34.63Mkr 835.66Kkr 608.17K
End Cash Position
kr 38.72Mkr ―kr 46.79Mkr 50.03Mkr 97.12M
Free Cash Flow
kr -43.05Mkr ―kr -37.86Mkr -47.92Mkr -40.90M
Currency in SEK

NextCell Pharma AB Cash Flow